Chongqing Pharscin Pharmaceutical Co., Ltd. at its annual general meeting of 2022 held on 19 May 2023, approved the Cash dividend/10 shares (tax included) is CNY 0.70000000 for 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
14.71 CNY | -1.28% | +1.87% | -4.79% |
04-10 | Chongqing Pharscin Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for the Year 2023 | CI |
04-03 | Pharscin Pharma Gets License to Produce Olmesartan Medoxomil Amlodipine Tablets | MT |
1st Jan change | Capi. | |
---|---|---|
-4.79% | 862M | |
+19.62% | 42.97B | |
+24.52% | 22.49B | |
+20.29% | 14.93B | |
+7.48% | 13.14B | |
+42.51% | 11.67B | |
-8.84% | 6.86B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+13.13% | 5.54B |
- Stock Market
- Equities
- 002907 Stock
- News Chongqing Pharscin Pharmaceutical Co., Ltd.
- Chongqing Pharscin Pharmaceutical Co., Ltd Approves the Cash Dividend for 2022